Your browser doesn't support javascript.
loading
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Gedde, Steven J; Feuer, William J; Lim, Kin Sheng; Barton, Keith; Goyal, Saurabh; Ahmed, Iqbal I K; Brandt, James D.
Afiliación
  • Gedde SJ; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: sgedde@med.miami.edu.
  • Feuer WJ; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
  • Lim KS; St. Thomas Hospital, London, United Kingdom.
  • Barton K; Moorfields Eye Hospital, London, United Kingdom.
  • Goyal S; Queen Mary's Hospital, Sidcup, United Kingdom.
  • Ahmed IIK; University of Toronto, Toronto, Canada.
  • Brandt JD; Department of Ophthalmology, University of California, Davis, Sacramento, California.
Ophthalmology ; 127(3): 333-345, 2020 03.
Article en En | MEDLINE | ID: mdl-31727428
PURPOSE: To report 3-year results of the Primary Tube Versus Trabeculectomy (PTVT) Study. DESIGN: Unmasked multicenter randomized clinical trial. PARTICIPANTS: Two hundred forty-two eyes of 242 patients with medically uncontrolled glaucoma and no previous incisional ocular surgery, including 125 in the tube group and 117 in the trabeculectomy group. METHODS: Patients were enrolled at 16 clinical centers and were assigned randomly to treatment with a tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC; 0.4 mg/ml for 2 minutes). MAIN OUTCOME MEASURES: The primary outcome measure was the rate of surgical failure, defined as intraocular pressure (IOP) of more than 21 mmHg or reduced less than 20% from baseline, IOP of 5 mmHg or less, reoperation for glaucoma, or loss of light perception vision. Secondary outcome measures included IOP, glaucoma medical therapy, visual acuity, and surgical complications. RESULTS: The cumulative probability of failure after 3 years of follow-up was 33% in the tube group and 28% in the trabeculectomy group (P = 0.17; hazard ratio, 1.39; 95% confidence interval, 0.9-2.2). Mean ± standard deviation IOP was 14.0±4.2 mmHg in the tube group and 12.1±4.8 mmHg in the trabeculectomy group at 3 years (P = 0.008), and the number of glaucoma medications was 2.1±1.4 in the tube group and 1.2±1.5 in the trabeculectomy group (P < 0.001). Serious complications requiring reoperation or producing loss of 2 or more Snellen lines developed in 3 patients (2%) in the tube group and 9 patients (8%) in the trabeculectomy group (P = 0.11). CONCLUSIONS: There was no significant difference in the rate of surgical failure between the 2 surgical procedures at 3 years. Trabeculectomy with MMC achieved lower IOP with use of fewer glaucoma medications compared with tube shunt surgery after 3 years of follow-up in the PTVT Study. Serious complications producing vision loss or requiring reoperation occurred with similar frequency after both surgical procedures.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trabeculectomía / Glaucoma / Implantes de Drenaje de Glaucoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trabeculectomía / Glaucoma / Implantes de Drenaje de Glaucoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Año: 2020 Tipo del documento: Article